Share on LinkedInShare on LinkedIn

ARTICLE · 04 FEBRUARY 2021

TGA announces major changes to regulation of software-based medical devices

Corrs Chambers Westgarth
Corrs Chambers Westgarth
Contributor
Corrs Chambers Westgarth

Corrs Chambers Westgarth

Corrs Chambers Westgarth is Australia’s leading independent law firm. We provide exceptional legal...

View firm profile
Explore more from Corrs Chambers Westgarth

The Therapeutic Goods Act (TGA) aims to ensure the safety of all medicines, biologicals and medical devices in Australia.

AustraliaConsumer Protection

The Therapeutic Goods Administration (TGA) has announced major changes to how software-based medical devices will be regulated under the Therapeutic Goods Act 1989 (Cth) (Therapeutic Goods Act).

There are three types of software-based medical devices affected by the changes:

  1. Devices referred to as 'programmed or programmable medical devices'.
  2. Software that is a medical device.
  3. Clinical decision support software (CDSS).

The changes will commence on 25 February 2021 and include:

  • the exclusion and exemption of certain software-based medical devices from regulation under the medical device regime under the Therapeutic Goods Act;
  • the introduction of new classification rules for software-based medical devices (these will impact both existing entries on the Australian Register of Therapeutic Goods (ARTG) and new entries for software-based medical devices); and

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

    Lawyers Weekly Law firm of the year 2021                  
Employer of Choice for Gender Equality (WGEA)

See more popular content from